Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: Preparation, characterization and in vivo evaluation

Expert Opinion on Drug Delivery

Volumn 10, Issue 4, 2013, Pages 411-420

  Dasgupta, Sandipan ^a   Dey, Sanjay ^a   Choudhury, Supratik ^a   Mazumder, Bhaskar ^a  

^a DIBRUGARH UNIVERSITY   (India)

Author keywords

Aceclofenac; Emulsification capability; Nanoemulsion; Topical delivery

Indexed keywords

ACECLOFENAC; DRUG VEHICLE; EXCIPIENT; HIFFNAC GEL; NE11; NE12; NE21; NE31; NG31; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; CONTROLLED STUDY; DRUG ANALYSIS; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; FEMALE; IN VIVO STUDY; MALE; NANOEMULSION; NONHUMAN; RAT; REFRACTION INDEX; REVIEW; SKIN PERMEABILITY; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DRUG DELIVERY SYSTEMS; EMULSIONS; EXCIPIENTS; GELS; MICROSCOPY, ELECTRON, TRANSMISSION; OILS; PERMEABILITY; RATS; REFRACTOMETRY; SKIN; SKIN ABSORPTION; SURFACE-ACTIVE AGENTS; THERMODYNAMICS; VISCOSITY;

EID: 84875180836     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.749234     Document Type: Review

References (25)

1. Sarzi-Puttini P, Cimmino MA, Scarpa R, et al. Osteoarthritis: An overview of the disease and its treatment strategies. Semin Arthritis Rheum 2005;35:1-10
2. Gerwin N, Hops C, Lucke A. Intra-articular drug delivery in osteoarthritis. Adv Drug Deliv Rev 2006;58:226-42
3. McKay N, Kelly CA. Extra-articular features of rheumatoid arthritis. Medicine 2006;34:383-6
4. Zarrin Ghalam Moghaddam J, Naghade M. Comparison of the effect of Hirudo medicinals and Pyroxicam capsule on reduction of inflammation and pain in the primary stages of rheumatoid arthritis of knee. Iranian J Pharm Res 2004;3(Suppl):43-3
5. Escribano E, Calpena AC, Queralt J, et al. Assessment of diclofenac permeation with different formulations: Anti-inflammatory study of a selected formula. Eur J Pharm Sci 2003;19:203-10
6. Yamazaki R, Kawai S, Mastsuzaki T. Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors. Eur J Pharmacol 1997;329:181-7
7. Gonzalez E, Cruz C, Nicolas R, et al. Long-term effects of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions 1994;41:171-8
8. Shaikh IM, Jadhav KR, Gide PS, et al. Topical delivery of aceclofenac from lecithin organogels: Preformulation study. Curr Drug Deliv 2006;3:417-27
9. Osborne DW, Ward AJ, Neil KJ. Microemulsions as topical delivery vehicles: In-vitro transdermal studies of a model hydrophilic drug. J Pharm Pharmacol 1991;43:450-4
10. Trotta M, Pattarino F, Gasco MR. Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions. Pharm Acta Helv 1996;71:135-40
11. Delgado-Charro MB, Iglesias-Vilas G, Blanco-Mendez J, et al. Delivery of a hydrophilic solute through the skin from novel microemulsion systems. Eur J Pharm Biopharm 1997;43:37-42
12. Dreher F, Walde P, Walter P, Wehrli E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release 1997;45:131-40
13. Schmalfus U, Neubart R, Wohlrab W. Modification of drug penetration into human skin using microemulsions. J Control Release 1997;46:279-85
14. Attwood D, Currie LRJ, Elworthy PH. Studies of Solubilized miceller solutions. Phase studies and particle-size analysis of solution formed with non-ionic surfactants. J Colloid Interface Sci 1974;46:249-54
15. Edwards DA, Langer R. A linear theory of transdermal transport phenomena. J Pharm Sci 1994;83:1315-34
16. Kulkarni SK, Jain NK. Pharmacological and pharmacokinetic studies on marketed gel formulations of nimesulide. Indian Drugs 2001;38(2):63-6
17. Babota S, Alam MS, Sharma S, et al. Nanocarrier-based hydrogel of betamethasone dipropionate and salicylic acid for treatment of psoriasis. Int J Pharm Investig 2011;1:139-47
18. Winter CA. Anti-inflammatory testing methods: Comparative evaluation of indomethacin and other agents. Nonsteroidal Anti Inflammatory Drugs 1965;52:190-202
19. Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev 1997;25:47-58
20. Warisnoicharoen W, Lansley AB, Lawrence MJ. Nonionic oil-in water microemulsions: The effect of oil type on phase behavior. Int J Pharm 2000;198:7-27
21. Eccleston J. Microemulsions. In: Boylan JC, Swarbrick J, editors. Encyclopedia of pharmaceutical technology. Volume 9 Marcel Dekker; NY: 1994. p. 375-421
22. Craig DQM, Barker SA, Banning D, Booth SW. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm 1995;114:103-10
23. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45:89-121
24. Klang V, Matsko N, Zimmermenn A, et al. Enhancement of stability and skin permeation of sucrose stearate and cyclodextrins in progesterone nanoemulsion. Int J Pharm 2010;393:152-60
25. Van-Abbe NJ, Nicholas P, Boon E. Exaggerated exposure in topical irritancy and sensitization testing. J Soc Cosmet Chem 1975;26:173-87